EFECTIVIDAD DE LOS NUEVOS TRATAMIENTOS PARA EL CÁNCER DE PRÓSTATA LOCALIZADO DE BAJO RIESGO.

Datos básicos

Protocolo:
TTOPRÓSTATA/OBS
EUDRACT:
NCT:
Centro:
Año de incio:
Año de finalización:
2020
ESTUDIO OBSERVACIONAL

Documentos

  • No hay documentos

Participantes

Financiadores - Promotores

FERRAN GUEDEA

Resultados del Ensayo Clínico


"Comments on: Clinical implementation of a new electronic brachytheropy system for skin brachytheropy" Reply

Pons-Llanas O; (...); Perez-Calatayud J

Letter. 10.5114/jcb.2015.53991. 2015

  • Open Access.

100% peer review in radiation oncology. Is it feasible?

Martin, E.; (...); Conde, A.

Meeting Abstract. 2020


100% peer review in radiation oncology: is it feasible?

Martin-Garcia E; (...); Conde-Moreno AJ

Review. 10.1007/s12094-020-02394-8. 2020

  • Open Access.

349 - Clinical usefulness of eight novel monoclonal antibodies against prostate-specific antigen (PSA) to differentiate prostate cancer and benign prostate hyperplasia. Measurement of different PSA molecular forms with specific immunoassays

S. Navarro; (...); P. Medina-Badenes

Article. 10.1016/S1569-9056(17)30413-X. 2017

  • Open Access.

A case report of recurrent adult-onset xanthogranuloma: is the radiotherapy a treatment option?

TUSET, P.; (...); Mico, AT

Article. 10.1007/s13691-015-0232-8. 2016

  • Open Access.

An evaluation of the robustness of organ-at-risk recommendations made by GEC/ESTRO according to interobserver variability: a single-center experience

Chicas-Sett R; (...); Perez-Calatayud J

Article. 10.5114/jcb.2016.61738. 2016

  • Open Access.

Are there enough radiation oncologists to lead the new Spanish radiotherapy?

Rodriguez, A; (...); Spanish Soc Oncology Radiotherapy

Article. 10.1007/s12094-019-02095-x. 2019


Clinical practice guidelines for the treatment of Ewing sarcoma (Spanish Sarcoma Research Group-GEIS).

Mata Fernández C; (...); Valverde Morales C

Article. 10.1007/s12094-024-03602-5. 2024

  • Open Access.

Dose escalation with HDR brachytherapy for intermediate- and high-risk prostate cancer

Chicas-Sett, R; (...); Tormo, A

Meeting Abstract. 10.1016/S0167-8140(17)31163-5. 2017


Efficacy and safety of electronic brachytherapy for superficial and nodular basal cell carcinoma

Ballester-Sánchez R; (...); Perez-Calatayud J

Article. 10.5114/jcb.2015.52140. 2015

  • Open Access.

Electronic brachytherapy for superficial and nodular basal cell carcinoma: a report of two prospective pilot trials using different doses

Ballester-Sanchez, R; (...); Botella-Estrada, R

Article. 10.5114/jcb.2016.57531. 2016


Endocrinological late effects of oncologic treatment on survivors of medulloblastoma

Santos, ADH; (...); Nieto, AC

Article. 10.32641/rchped.v90i6.994. 2019


Fetal dose measurements and shielding efficiency assessment in a custom setup of Ir-192 brachytherapy for a pregnant woman with breast cancer

Candela-Juan, C; (...); Perez-Calatayud, J

Article. 10.1016/j.ejmp.2015.01.010. 2015


High-dose-rate brachytherapy boost for prostate cancer: Analysis of dose-volume histogram parameters for predicting late, rectal toxicity

Chicas-Sett, R; (...); Perez-Calatayud, J

Article. 10.1016/j.brachy.2017.03.002. 2017


Impact of real-time, dose-escalated permanent seed implant brachytherapy in intermediate-risk prostate cancer

Pons-Llanas, O; (...); Lopez-Torrecilla, J

Article. 10.1016/j.rpor.2020.04.014. 2020

  • Open Access.

Internal dose-escalation with FFF-VMAT and advantages in SRS metastasis treatments

Perez Calatayud, M. J.; (...); Tormo, A.

Meeting Abstract. 2020


Interobserver variability in rectum contouring in high-dose-rate brachytherapy for prostate cancer: A multi-institutional prospective analysis

Chicas-Sett, R; (...); Perez-Calatayud, J

Article. 10.1016/j.brachy.2017.09.015. 2018


Intravascular Biphasic Synovial Sarcoma: The Beneficial Role of Adjuvant Treatment Approach in the Pre-metastatic Stage.

Chicas-Sett R; (...); Tormo A

Article. 10.7759/cureus.572. 2016


Novel simple templates for reproducible positioning of skin applicators in brachytherapy

Villalba, SR; (...); Ballester, F

Review. 10.5114/jcb.2016.61713. 2016

  • Open Access.

Outcomes and prognostic factors in intermediate-risk prostate cancer: multi-institutional analysis of the Spanish RECAP database

Hervás A; (...); Clemente J

Article. 10.1007/s12094-018-02000-y. 2019


Permanent seed implant brachytherapy in low-risk prostate cancer: Preoperative planning with 145?Gy versus real-time intraoperative planning with 160?Gy.

Pons-Llanas, O; (...); Lopez-Torrecilla, JL

Article. 10.1016/j.rpor.2018.06.009. 2018

  • Open Access.

Salvage I-125 brachytherapy for locally-recurrent prostate cancer after radiotherapy

Pons-Llanas O; (...); López-Torrecilla J

Article. 10.1016/j.rpor.2020.06.010. 2020

  • Open Access.

Small cone vs microMLC in SRS trigeminal neuralgia: Dosimetric improvement

Perez Calatayud, M. J.; (...); Tormo, A.

Meeting Abstract. 2020


Survival after Biochemical Failure in Prostate Cancer Treated with Radiation Therapy

Gonzalez, C; (...); Lopez-Torrecilla, J

Meeting Abstract. 10.1016/j.ijrobp.2018.07.309. 2018

  • Open Access.

Survival after biochemical failure in prostate cancer treated with radiotherapy: Spanish Registry of Prostate Cancer (RECAP) database outcomes

Gonzalez-San Segundo, C; (...); Lopez-Torrecilla, J

Article. 10.1007/s12094-018-02021-7. 2019


Two years results of electronic brachytherapy for basal cell carcinoma

Ballester-Sánchez R; (...); Botella-Estrada, R

Article. 10.5114/jcb.2017.68191. 2017

  • Open Access.

Campos de Estudio

Compartir